UAE-based Imperial College London Diabetes Centre (ICLDC), a part of Mubadala Healthcare, said it has received two global endorsements from the Joint Commission International (JCI) within just six months since its opening.

An UAE-based specialist medical centre, ICLDC Al Ain was granted JCI accreditation in ambulatory care and JCI certification in clinical care program for diabetes management, both held by ICLDC Abu Dhabi since 2009 and 2010, respectively.

The Al Ain centre opened in September last year as part of Mubadala Healthcare’s strategy to bring world-class medical expertise to the region. The first centre opened in Abu Dhabi in 2006.

“Providing our patients with internationally recognised standards of quality care is paramount and I am delighted that ICLDC’s Al Ain facility has achieved this recognition after only six months,” remarked Suhail Mahmood Al Ansari, the executive director of Mubadala Healthcare and chairman of ICLDC.

“This accomplishment is testament to the tremendous clinical leadership at the Centre, the expertise provided by our partner Imperial College and the hard work and determination of the whole team,” he stated.

Dr Maha Taysir Barakat, ICLDC’s medical & research director and consultant endocrinologist said it was still the only medical facility in the world to hold both the JCI certifications.

Lauding the ICLDC for its success,  Ann Jacobson, the executive director of International Accreditation for JCI said: “The citizens of the UAE should be proud that Imperial College London Diabetes Centre continues to focus on this most challenging goal – to continuously raise quality to higher levels.”

Since 1994, JCI has worked alongside healthcare organisations, health ministries and global organisations in more than 80 countries to improve patient care through the provision of accreditation and certification services, among other services.-TradeArabia News Service